Loading clinical trials...
Loading clinical trials...
A Phase 2, Multi-center, Double-blind, Randomized, Vehicle-controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects With External Genital Warts and Perianal Warts
Conditions
Interventions
NVN1000 8% Gel
NVN1000 16%
+2 more
Locations
15
United States
PPD 137
Fountain Valley, California, United States
PPD 140
Lomita, California, United States
PPD 133
San Diego, California, United States
PPD 134
Atlanta, Georgia, United States
PPD 139
Atlanta, Georgia, United States
PPD 138
Roswell, Georgia, United States
Start Date
June 12, 2015
Primary Completion Date
October 1, 2016
Completion Date
October 17, 2016
Last Updated
April 6, 2023
NCT00092534
NCT06915779
NCT06700941
NCT06691542
NCT06681636
NCT05156541
Lead Sponsor
Novan, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions